New Zealand markets open in 3 hours

Perspective Therapeutics, Inc. (CATX)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
1.4950+0.0050 (+0.34%)
As of 03:00PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
30/06/2022
30/06/2021
30/06/2020
30/06/2019
Total revenue
0
0
10,795
10,053
9,680
-
Cost of revenue
-
-
6,179
4,932
4,556
4,267
Gross profit
-
-
4,616
5,121
5,124
3,047
Operating expenses
Research development
25,454
21,311
2,582
1,427
1,126
-
Selling general and administrative
20,279
21,064
9,425
7,131
7,547
-
Total operating expenses
44,207
40,941
12,007
8,558
8,600
-
Operating income or loss
-44,207
-40,941
-7,391
-3,437
-3,476
-
Interest expense
95
84
-
-
-
-
Total other income/expenses net
5
-15
-
-9
-
26
Income before tax
-42,526
-40,106
-7,272
-3,387
-3,446
-
Income tax expense
7,849
-2,651
-
-
-
-
Income from continuing operations
-50,375
-37,455
-7,272
-3,387
-3,446
-
Net income
-58,421
-46,508
-7,272
-3,387
-3,446
-
Net income available to common shareholders
-58,421
-46,508
-7,272
-3,390
-3,457
-
Basic EPS
-0.04
-0.17
-0.05
-0.03
-0.05
-
Diluted EPS
-0.04
-0.17
-0.05
-0.03
-0.05
-
Basic average shares
136,823
267,643
141,987
103,841
67,601
-
Diluted average shares
136,823
267,643
141,987
103,841
67,601
-